Login / Signup

A novel quantitative PCR detects Babesia infection in patients not identified by currently available non-nucleic acid amplification tests.

Lavoisier AkooloSamantha SchlachterRasel KhanLaura AlterAlbert D RojtmanKristine GedroicPurnima BhanotNikhat Parveen
Published in: BMC microbiology (2017)
Robust qPCR using specific probes can be highly useful for efficient and appropriate diagnosis of babesiosis in patients in conjunction with conventional diagnostics, or as a stand-alone test, especially for donated blood screening. The use of a nucleic acid amplification test based screening of blood and blood products could prevent TTB.
Keyphrases
  • nucleic acid
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • mass spectrometry